HOME
HIV-HCV Coinfection
Hepatitis C
HIV and AIDS
Hepatitis B
HIV-HBV Coinfection
HIV-HCV Coinfection
HIV-HCV Coinfection Top News Articles
Treatment of Patients with HIV-HCV Coinfection: An Overview
HCV-Related Liver Fibrosis Is More Severe in HIV Positive Individuals Despite Antiretroviral Therapy - 6/24/08
Abdominal Fat Accumulation, Elevated ALT, and Liver Steatosis in HIV Positive Individuals - 6/20/08
Profile of Patients Triply-infected with HIV, Hepatitis B and Hepatitis C - 6/16/08
Liver Biopsies Reveal No Evidence of Mitochondrial Damage in HIV-HCV Coinfected Individuals on HAART - 6/13/08
Influence of Occult Hepatitis B Virus on Liver Disease Progression and Response to Interferon-based Therapy in HIV-HCV Coinfected Patients - 6/10/08
HIV Coinfection May Interfere with Immune Response to Hepatitis C Virus - 6/06/08
Long-term Alcohol Abuse Is Linked to Worse Liver Fibrosis in HIV Positive Veterans with or without HCV Coinfection - 6/03/08
Sexual Transmission of HCV and Triple Infection with HBV Predict Spontaneous HCV Clearance in HIV-HCV Coinfected Individuals - 5/30/08
Higher LDL Cholesterol Predicts Better Response to Interferon-based Therapy in HIV-HCV Coinfected Patients - 5/23/08
Insulin Resistance Impairs Rapid Virologic Response to Interferon-based Therapy in HIV-HCV Coinfected Patients - 5/13/08
Virological Response Is Similar in HCV Monoinfected and HIV-HCV Coinfected Patients with HCV Genotypes 2 or 3 - 5/13/08
Liver Transplant Outcomes in HIV Positive Patients with Viral Hepatitis - 4/29/08
Altered Cytokine Levels May Explain More Rapid Liver Fibrosis Progression in HIV-HCV Coinfected Individuals  - 4/15/08
Prevalence and Outcomes of Liver Cirrhosis in HIV Positive People  - 4/11/08
Liver Steatosis Is Common in People with HIV-HCV Coinfection and Is Linked to Advanced Fibrosis - 4/01/08
Severe Weight Loss Can Be a Side Effect of Interferon-based Therapy in HIV-HCV Coinfected Patients - 3/28/08
Liver Steatosis and its Effect on Hepatitis C Treatment in HIV-HCV Coinfected Individuals - 3/21/08
Acute HIV-HCV Coinfection Increasingly Common in U.K.; Sexually Transmitted HCV Superinfection Reported in France - 3/18/08
Researchers Uncover Clues to How HIV Promotes Hepatitis C Virus Replication - 3/14/08
Cyclophilin Inhibitor Debio-025 Demonstrates Potent Anti-HCV Activity in HIV-HCV Coinfected Patients - 3/14/08
Insulin Resistance Reduces the Likelihood of Sustained Response to Hepatitis C Treatment in HIV-HCV Coinfected Patient - 3/11/08
Liver Fibrosis Progression in HIV-HCV Coinfected Patients Treated with Interferon plus Ribavirin - 3/11/08
Survival and Recurrence of Hepatitis C after Liver Transplantation in HIV-HCV Coinfected Patients - 3/07/08
Treatment of Acute Hepatitis C in HIV Positive Individuals - 3/04/08
Do HIV-HCV Coinfected Patients Have Impaired CD4 Cell Recovery after Starting HAART - 2/29/08
MELD Score Is the Best Predictor of Outcomes among HIV Positive Liver Transplant Recipients - 2/19/08
Vicriviroc Is Safe in HIV-HCV Coinfected Patients, but Does Not Show Activity against HCV - 2/15/08
Rates and Risk Factors for Liver Fibrosis Progression in HIV-HCV Coinfected Individuals - 2/15/08
Long-term Pegylated Interferon Maintenance Therapy Demonstrates No Benefit in HIV-HCV Coinfected Patients - 2/12/08
Fibrosis Status of HIV-HCV Coinfection Patients with Normal ALT Levels - 2/05/08
AZT (Retrovir) Ups Anemia Risk in HIV-HCV Coinfected Patients, But Rate Remains Low - 2/01/08
Elevated Risk of Hepatitis-related Death in HIV-HCV Coinfected Drug Users - 1/29/08
GBV-C Protects against Liver Disease Progression in HIV-HCV Coinfected Individuals - 1/25/08
Impaired Anger Control Is a Possible Side Effect of Hepatitis C Treatment in HIV-HCV Coinfected Patients - 1/18/08
Nevirapine (Viramune) Is Linked with Reduced Liver Fibrosis Progression in HIV-HCV Coinfected Patients - 1/14/08
Accelerated Liver Disease Progression in HIV-HCV Coinfected Patients May Be Due to Increased Liver Inflammation - 1/11/08
Undetectable HCV Viral Load at Week 4 of Pegylated Interferon plus Ribavirin Predicts Sustained Response in HIV-HCV Coinfected Patients - 1/11/08
Effect of Baseline CD4 Cell Count on Efficacy and Safety of Pegylated Interferon plus Ribavirin in HIV-HCV Coinfected Patients - 1/04/08
Antiretroviral Therapy Improves Poor Prognosis among HIV-HCV and HIV-HBV Coinfected Patients with Liver Cirrhosis - 12/14/07
HCV Coinfection Is Linked to Diabetes in HIV Positive Patients without Other Risk Factors - 12/11/07
Liver Enzyme Elevation and Immune Reconstitution in HIV Patients with and without Hepatitis B or C Coinfection - 12/07/07
Early Anti-HCV Activity of Pegasys and PegIntron Are Similar in HIV-HCV Coinfected Patients - 12/04/07
Sexual Transmission of HCV among HIV Positive Men Who Have Sex with Men in France - 11/30/07
Weight-based Ribavirin Increases Sustained Response Rate among HIV-HCV Coinfected Genotype 1 Patients, but also Raises Risk of Anemia - 11/30/07
Similar Response Rates and Disease Progression in HIV-HCV Coinfected and HCV Monoinfected Patients - 11/27/07
Biological Mechanisms Underlying Accelerated Liver Disease Progression in HIV-HCV Coinfected Individuals - 11/27/07
Retreatment with Pegylated Interferon alfa-2a (Pegasys) plus Weight-based Ribavirin in HIV-HCV Coinfected Non-responders and Relapsers to Prior Hepatitis C Treatment: The PILOT-NR Study - 11/20/07
Boosted Fosamprenavir (Lexiva) Linked to Increased Anti-HCV Immune Response and Lower HCV Viral Load in HIV-HCV Coinfected Patients - 11/16/07
Abacavir (Ziagen) in HAART Regimen May Reduce Response to Hepatitis C Treatment in Coinfected Individuals - 11/16/07

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reports on Most Recent
HIV- and Hepatitis-related Research Conferences

DDW 2008 - May 2008 
EASL 2008 - April 2008 
CROI 2008 - February 2008 
AASLD2007 - November 2007 
IAS 2007 - July 2007 


FDA-approved Hepatitis C
Treatments

Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin
-
Treatment Guidelines
-
Experimental Treatments

FDA-approved HIV and
AIDS Treatments

Protease Inhibitors PIs
non Nucleoside Reverse
  
Transcriptase Inhibitors nNRTIs
Nucleoside / Nucleotide Reverse
  
Transcriptase Inhibitors NRTIs

Fixed-dose Combinations

Entry / Fusion Inhibitors EIs
Integrase Inhibitors
-
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
-Guidelines for Treatment of HIV-related OIs
-
Experimental Treatments


Website Sponsors